MIXED LINEAGE ACUTE LEUKEMIA
Clinical trials for MIXED LINEAGE ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED LINEAGE ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for MIXED LINEAGE ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat leukemia: first patients test novel drug
Disease control Recruiting nowThis is the first time a new drug called ziftomenib is being tested in people. The study aims to find a safe and effective dose for adults with advanced acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) that has returned or not responded to other treatments. It w…
Matched conditions: MIXED LINEAGE ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill targets Tough-to-Treat blood cancers in major trial
Disease control Recruiting nowThis study is testing a new oral medication called revumenib for people with acute leukemias that have come back or not responded to standard treatments. The first part of the study aims to find the safest and most effective dose. The second part will test how well the drug works…
Matched conditions: MIXED LINEAGE ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC